[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-339269-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-339269-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","exosome-coated-prussian-blue-nanoparticles-for-specific-targeting-and-treatment-of-glioblastoma","Exosome-Coated Prussian Blue Nanoparticles for Specific Targeting and Treatment of Glioblastoma","","Glioblastoma is an extremely aggressive brain cancer with a 5-year survival rate of 6.8%, limited therapeutic options, and a frequent transition to palliative care. A theranostic platform is needed for early diagnosis and noninvasive treatment, because current peptide-based delivery can cause off-target effects and cannot reliably cross the blood–brain barrier (BBB). Exosome-coated Prussian Blue nanoparticles (Exo:PB), using a PBNP core and U-87 cancer cell–derived exosome coating, provide complete exosome-marker coating, brain tumor–specific targeting, and localized photothermal cell death under 808 nm laser exposure.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/exosome-coated-prussian-blue-nanoparticles-for-specific-targeting-and-treatment-of-glioblastoma/339269/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/exosome-coated-prussian-blue-nanoparticles-for-specific-targeting-and-treatment-of-glioblastoma/339269.png","ImageObject",300,407,{"name":42,"@type":43},"Emma Wilson","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-24","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"Why are exosome-coated Prussian Blue nanoparticles (Exo:PB) proposed for glioblastoma?","Question",{"text":63,"@type":64},"Exo:PB aims to enable BBB crossing and tumor-specific delivery while leveraging strong photoconversion for combined diagnosis and photothermal therapy, addressing off-target limitations of peptide-based approaches.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What imaging and treatment mechanisms are highlighted for Exo:PB?",{"text":68,"@type":64},"The nanoparticles support photoacoustic imaging to detect brain tumor regions and photothermal ablation under NIR laser excitation to reduce tumor mass and induce localized cell death.",{"name":70,"@type":61,"acceptedAnswer":71},"How is Exo:PB compared to PEG-coated or control nanoparticle formulations?",{"text":72,"@type":64},"The study reports preferential tumor accumulation with less off-targeting relative to controls such as PEG-coated PBNPs (PEG:PB) and RGD:PB, including validation by histology and proliferation markers.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},339269,1790578316,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":33,"preview_urls":145},3848291630094,"https://eur-avatar.wpscdn.com/davatar_085a072bc5b1113ac321206ff7593b45","This article is licensed under CC-BY 4.0   \n[www.acsami.org](www.acsami.org)  Research Article   \nExosome-Coated Prussian Blue Nanoparticles for Specific Targeting and Treatment of Glioblastoma  \nMeghan L. Hill, Seock-Jin Chung, Hyun-Joo Woo, Cho Rong Park, Kay Hadrick, Md Nafiujjaman, Panangattukara Prabhakaran Praveen Kumar, Leila Mwangi, Rachna Parikh, and Taeho Kim*  \n Cite This: ACS Appl. Mater. Interfaces 2024, 16, 20286−20301  \nRead Online  \n\n|  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- |\n| ACCESS   | Metrics & More |  |  Article Recommendations |  | *sı Supporting Information |\n\nABSTRACT: Glioblastoma is one of the most aggressive and invasive types of brain cancer with a 5-year survival rate of 6.8%. With limited options, patients often have poor quality of life and are moved to palliative care after diagnosis. As a result, there is an extreme need for a novel theranostic method that allows for early diagnosis and noninvasive treatment as current peptide-based delivery standards may have off-target effects. Prussian Blue nanoparticles (PBNPs) have recently been investigated as photoacoustic imaging (PAI) and photothermal ablation agents. However, due to their inability to cross the blood−brain barrier (BBB), their use in glioblastoma treatment is limited. By utilizing a hybrid, biomimetic nanoparticle composed of a PBNP interior and a U-87 cancer cell-derived exosome coating (Exo:PB), we show tumor-specific  \ntargeting within the brain and selective thermal therapy potential due to the strong photoconversion abilities. Particle characterization was carried out and showed a complete coating around the PBNPs that contains exosome markers. In vitro cellular uptake patterns are similar to native U-87 exosomes and when exposed to an 808 nm laser, show localized cell death within the specified region. After intravenous injection of Exo:PB into subcutaneously implanted glioblastoma mice, they have shown effective targeting and eradication of tumor volume compared to PEG-coated PBNPs (PEG:PB). Through systemic administration of Exo:PB particles into orthotopic glioblastoma-bearing mice, the PBNP signal was detected in the brain tumor region through PAI. It was seen that Exo:PB had preferential tumor accumulation with less off-targeting compared to the RGD:PB control. Ex vivo analysis validated specific targeting with a direct overlay of Exo:PB with the tumor by both H&E staining and Ki67 labeling. Overall, we have developed a novel biomimetic material that can naturally cross the BBB and act as a theranostic agent for systemic targeting of glioblastoma tissue and photothermal therapeutic effect.  \nKEYWORDS: theranostics, molecular imaging, glioblastoma, exosome, Prussian blue nanoparticles, photoacoustic imaging, photothermal therapy  \n■ INTRODUCTION  \nGlioblastoma is the most aggressive type of primary brain cancer that has a 5-year survival rate of 6. 8%.1 Common symptoms include headaches, problems with speech, memory loss, confusion, and vision problems.2,3 Due to the overlapping nature of these symptoms with many other neurological disorders, glioblastoma can be extremely difficult to diagnose without expensive imaging and invasive procedures. In addition, diagnostic procedures are painful for the patient to undergo before starting therapy. Even after diagnosis, there are few chemotherapy or radiation treatment options available to the patient due to the impenetrable nature of the blood−brain barrier (BBB).4−6 Unfortunately, this often leads to palliative care for patients diagnosed with glioblastoma.  \nNanoparticles have become a novel approach for diagnosticsand therapeutics in brain-related diseases.6,7 Prussian Blue nanoparticles (PBNPs) are FDA-approved agents for treating radiation exposure.8 They work by absorbing heavy metals into their cubic matrix, allowing for efficient disposal through the  \nbody.9 With an intense light absorbance in the biological transparency window (peak absorbance between 700 a","cbCaitm0AhUNWjYn","https://ap.wps.com/l/cbCaitm0AhUNWjYn","pdf",2877815,16,"English","# Abstract\n# Introduction\n## Clinical challenges in glioblastoma diagnosis and treatment\n## Rationale for Prussian Blue nanoparticles in phototheranostics\n## BBB limitation and biomimetic exosome coating approach\n# Figure 1: Targeting, therapeutic effect, and photoacoustic detection","[{\"question\":\"Why are exosome-coated Prussian Blue nanoparticles (Exo:PB) proposed for glioblastoma?\",\"answer\":\"Exo:PB aims to enable BBB crossing and tumor-specific delivery while leveraging strong photoconversion for combined diagnosis and photothermal therapy, addressing off-target limitations of peptide-based approaches.\"},{\"question\":\"What imaging and treatment mechanisms are highlighted for Exo:PB?\",\"answer\":\"The nanoparticles support photoacoustic imaging to detect brain tumor regions and photothermal ablation under NIR laser excitation to reduce tumor mass and induce localized cell death.\"},{\"question\":\"How is Exo:PB compared to PEG-coated or control nanoparticle formulations?\",\"answer\":\"The study reports preferential tumor accumulation with less off-targeting relative to controls such as PEG-coated PBNPs (PEG:PB) and RGD:PB, including validation by histology and proliferation markers.\"}]","Exosome-Coated Prussian Blue Nanoparticles for Specific Targeting and Treatment of Glioblastoma | PDF",1790029068,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d848f524f5f3ce76b0a5767d773632fd.webp",983,1296,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/923d4baa5836bd902d395ecf2df4826f.webp",982,1295,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5e497651b285f2695203e77fcc2f10c2.webp",981,1293,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/934baabdfa40c92aa4b4383f036bf706.webp",980,1292]